Craig-Hallum analyst Alexander Nowak started coverage of Sensus Healthcare with a Buy rating and $10 price target. The analyst notes that the company’s SRT-100 is 11% penetrated and with new indications and improving reimbursement, he expects adoption to ramp. Sensus is a $100M market cap today facing a near term $5B opportunity, he contends, adding that if the company is successful just with its current systems, market cap can move multiples higher.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.